Altis Biosystems

Altis Biosystems is a spin-out company from the University of North Carolina at Chapel Hill and based in Durham, North Carolina. The intellectual property behind its stem cell platform was created as part of an NIH Transformative Research Award to develop a microfluidic organ-on-a-chip mimic of the human colon and awarded to Altis’ scientific founders. Altis’ platform produces a layer of human intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for compound screening, disease modeling, and microbiome research.Altis’s mission is to develop, manufacture and sell innovative services and research tools to accelerate drug development. Our goal is to reduce the time and cost of drug development with in vitro platforms that more accurately reflect native human biology. https://altisbiosystems.com/